Badger Meter, Inc. (NYSE: BMI) — A Debt-Free Water Compounder, De-Rated to a Decade-Cheap Multiple on a Growth Air Pocket

Independent equity research — for general information only Report date: June 14, 2026 · Price: $131.73 (June 12, 2026) · Market cap ~$3.9B · Net cash ~$226M

⚡ Claude’s Take

This block is the author’s own subjective opinion. It is general information, not investment advice, and not a recommendation to buy or sell any security. The analysis that follows takes no position and names no price target; this block alone takes a view.

Verdict: ACCUMULATE-ON-WEAKNESS / constructive HOLD. A genuinely wide-moat water-technology compounder whose multiple has exhaled from a nosebleed ~50x to a decade-cheap ~30x P/E — but “cheap versus itself” is not the same as “cheap.” Conviction: medium. Catchy tag: the falling knife that finally looks like a business again.

Badger Meter is the rare combination quality investors prize: ~21% ROIC, gross margins rising to 41.7%, a debt-free balance sheet with $226M of net cash, 33 consecutive years of dividend increases, a sticky municipal-utility customer base, a recurring-software layer compounding at ~28%, and a management team whose long-term incentive is literally 50% ROIC and 50% free-cash-conversion. Over the past twelve months the stock fell ~45% — and the decline is idiosyncratic (a factor/risk model puts the market-factor R² at just 0.21; this is not a factor rotation, it is company-specific). The cause is a telegraphed growth air pocket: a concentrated cohort of large smart-metering (AMI) projects plus a chip-shortage backlog catch-up inflated 2023–24 growth to 16–24%, and as that cohort rolled off, Q1 2026 sales fell 9% and management guided 2026 to roughly flat. The market is pricing a structural break; management, the insiders (the CEO bought twice and the CFO twice into the drop), and the >3x-larger awarded-project funnel all argue timing.

Where I land short of a full buy: the honest valuation read is that the 6th-percentile P/E is partly a peak-earnings artifact (trailing EPS still carries the boom cohort), and on price-to-sales BMI sits at the 45th percentile of its own decade — mid-range, not washed out. After a 45% fall it still trades at a premium to its metering peers (Itron ~15–19x at ~7% ROIC; Mueller ~19x), justified by quality but not a screaming bargain. A reverse-DCF says today’s ~$4.9B EV embeds ~5.25% perpetual FCF growth — reasonable for the secular AMI runway plus the software ramp, so the price is fair, not gifted. My constructive lean rests on the quality, the insider cluster, the funnel, and the de-rate; my restraint rests on the peak-E flatter and the peer premium. Directional zone: I’d accumulate in the ~$110–125 band (~23–26x normalized ~$4.75 EPS, ~20x EV/EBITDA) and stop chasing above ~$165–175 (back toward 35x). At $131 it sits in a fair, lean-constructive zone — a name to build into on weakness, not to lunge at. Flips bullish: Q2/Q3 2026 short-cycle orders re-accelerate and PRASA ramps on schedule (trough confirmed). Flips bearish: 2027 organic settles at low-single-digit, confirming the boom was a one-time pull-forward rather than a pause.

1. Executive Summary

Badger Meter is a 120-year-old Milwaukee manufacturer that has quietly become one of the highest-quality businesses in the water-infrastructure value chain. It sells water meters — mechanical and, increasingly, ultrasonic — together with the ORION radio endpoints, BEACON cloud software, and a widening “beyond-the-meter” suite (water-quality sensing, pressure/leak detection, and sewer-network monitoring) under the BlueEdge brand. Roughly 89% of revenue is utility water and ~95% is water-related; the customers are municipal water utilities, among the stickiest, most credit-worthy, and most replacement-driven buyers in the industrial economy.

The financial signature is unambiguous quality. Revenue nearly doubled from $425M (FY20) to $917M (FY25); gross margin expanded ~220bps to 41.7% and operating margin ~470bps to 20.0%; ROIC rose from ~14% to ~21%; the company carries zero long-term debt and $226M of net cash; operating cash flow has exceeded net income in every year (1.2–1.3x); and the dividend has been raised for 33 consecutive years. This is a business whose economics demonstrably improve with scale, and whose moat — customer captivity at risk-averse utilities, a razor/razorblade endpoint-plus-software pull-through, brand reliability, and a network-as-a-service recurring layer — is evidenced in the returns rather than merely asserted.

The investment question is not whether BMI is a good business; it plainly is. The question is price and growth durability. From 2023 to early 2025 the stock carried a ~50x earnings multiple, pricing low-double-digit perpetual growth. Then a concentrated cohort of large AMI deployment projects (~800k connections) that had supercharged 2023–24, layered on top of a chip-shortage backlog catch-up, rolled off. Management telegraphed the deceleration through 2025; Q1 2026 confirmed it with a 9% sales decline, a collapse in operating margin to 17.4% (from a record 22.2%), EPS of $0.93 versus $1.30, and an explicit guide to roughly flat 2026 organic revenue. The shares fell ~45% over twelve months and the P/E compressed to ~30x — the 6th percentile of its own decade.

The bull case is that this is a timing air pocket: ~85% of annual demand is non-discretionary meter/radio replacement, the awarded-but-not-started project funnel has grown to 2.6–3.6M connections (more than 3x the prior cohort), seven of nine awarded projects are competitive conversions BMI has won, the recurring-software layer is compounding, and insiders bought aggressively into the drop. The bear case is that the 2021–24 boom was a one-time confluence — backlog catch-up plus a pulled-forward cellular-AMI wave plus lumpy projects plus one acquisition — and that normalized organic growth is mid-single-digit and lumpy, which does not deserve a premium-to-peers ~30x multiple, particularly because the “cheap” trailing P/E sits on peak earnings. This memo lays out both sides and the falsification tests that will resolve them — chiefly the 2H26 short-cycle order recovery and the on-time ramp of the awarded funnel led by Puerto Rico’s PRASA.

2. Business Overview

What the company does. Badger Meter provides flow measurement, quality, control, and communication solutions, overwhelmingly for the water cycle. The business is organized — and reported in the 10-K — across two product lines:

• Utility Water (~89% of FY2025 sales, ~$816M). Water meters (mechanical and ultrasonic) sold to municipal and investor-owned water utilities, bundled with the company’s proprietary communications and software: ORION radio endpoints (mobile/drive-by AMR, fixed-network, and the differentiated ORION Cellular “network-as-a-service” option), the BEACON cloud-hosted advanced-metering-analytics SaaS platform, and the broadening “beyond-the-meter” portfolio — s::can water-quality sensing, Syrinix pressure/leak/transient monitoring, and SmartCover/Hadronex sewer-line, lift-station and stormwater monitoring. The whole offering is marketed as the BlueEdge suite (hardware + communications + software + services).
• Flow Instrumentation (~11% of FY2025 sales, ~$101M). Electromagnetic, turbine, Coriolis, and other meters, valves, and sensors sold to OEMs and industrial customers — measuring water, air, steam, oil, and gases in industrial process, HVAC, and water/wastewater treatment. This line is flat-to-declining (FY25 ~−0.5%) and is the lower-growth, more-cyclical tail of the business.

How it makes money. Historically a hardware company — a meter and a radio sold once, with a 15–20-year field life — Badger Meter is mid-transition toward a systems-and-subscription model. Each ORION Cellular endpoint and each AMI deployment pulls through a BEACON SaaS subscription (the software attaches ~100% to cellular radios), plus the ORION Cellular network-as-a-service revenue (BMI manages the cellular connectivity so the utility never builds or owns fixed-network towers). Beyond-the-meter products (SmartCover, water quality, network monitoring) carry their own recurring monitoring/service revenue.

Recurring mix — real, fast, still small. Recurring/over-time revenue (SaaS + services) reached $89.7M, or 9.8% of FY2025 sales, up from 7.1% in FY2024 (+53% YoY); management’s narrower “software” figure (including SmartCover) is ~$74M, “100% recurring,” compounded at ~28% over five years. This is genuine and strategically central — but it is still ~10% of the company, so today’s margin and growth profile are driven by hardware mix, not software scale. (Interpretation: the SaaS lock-in narrative runs slightly ahead of the numbers; the moat today is evidenced by hardware ROIC, with the annuity layer a credible — not yet dominant — future.)

Revenue character. Roughly 75% of revenue is sold direct (the balance through reps/resellers); the majority is short-cycle (distribution and non-project direct orders), with a smaller but highly visible layer of large multi-year AMI projects that are either “supply-only” (BMI ships meters/radios/software at higher margin) or “turnkey” (BMI acts as prime contractor, including pass-through installation labor and meter pits/lids — far higher revenue, materially lower margin). This supply-vs-turnkey mix is the single biggest swing factor in quarterly revenue and gross margin, and it is central to understanding both the 2023–24 boom and the 2025–26 air pocket.

The unit economics — why the installed base compounds. The economic engine is a razor/razorblade dynamic with an unusually long fuse. A utility buys a meter and an ORION endpoint once (the “razor”); the endpoint then pulls through, over its 10–20-year life, a recurring stream of BEACON SaaS subscriptions and — for ORION Cellular — managed-connectivity revenue (the “blades”). Because the field life is so long and the customer so sticky, every endpoint shipped today seeds a multi-decade annuity, and the recurring base grows mechanically as the installed fleet expands and the AMI attach rate rises. This is why the recurring layer compounded ~28% while total revenue grew in the low-teens: it is layering subscriptions on a growing hardware base. The implication for value is that BMI’s reported earnings understate the economic value being created, because the lifetime subscription value of a year’s endpoint shipments is recognized over a decade-plus rather than at sale — a genuine (if currently small) embedded asset not visible on the income statement.

Verdict. A focused, high-quality water-infrastructure franchise with a genuine and accelerating recurring layer grafted onto a sticky replacement-hardware core. The revenue base is ~95% water, ~85% non-discretionary replacement, and increasingly subscription-attached — a structurally attractive model, with the caveat that project lumpiness makes quarterly results far more volatile than the secular demand would suggest.

3. Industry Dynamics

Structure and size. Badger Meter sits in the smart water metering / advanced metering infrastructure (AMI) market — estimated at roughly $9B globally in 2024 and growing to ~$16B by 2030 (~10% CAGR; the AMI sub-segment ~12%). The secular drivers are durable and well-understood: aging US water infrastructure (much of it decades past design life), chronic non-revenue water loss (utilities lose 15–30% of treated water to leaks and under-measurement), conservation and drought pressure, regulatory and ratepayer demands for usage transparency, and federal funding (the Infrastructure Investment and Jobs Act and FEMA disaster funding). Critically, only ~40% of US water meters are AMI-converted, leaving a multi-decade replacement-and-upgrade runway as utilities migrate from manual reads → AMR (drive-by) → AMI (fixed/cellular two-way).

Competitive intensity — a concentrated oligopoly. The market is dominated by a handful of credible names: Itron (ITRI) — the AMI water share leader; Sensus, owned by Xylem (XYL); Neptune, owned by Roper; Mueller Water Products (MWA); and the European players Kamstrup and Diehl, plus Aclara, Master Meter, and Arad. This is not a fragmented commodity market: the top five or six suppliers hold the bulk of share. Barriers to entry are high and underappreciated — utilities are intensely risk-averse, demand 15–20-year proven field reliability, require regulatory and accuracy certifications (NSF/AWWA), and buy through entrenched manufacturer-rep distribution relationships. A new entrant cannot simply undercut on price; it must demonstrate a decade of reliability that it does not have.

The technology axis — cellular vs. fixed-network. Badger Meter’s strategic wedge is ORION Cellular: rather than sell a utility a fixed-network system (towers, collectors, capital, and IT burden — Itron’s traditional model), BMI offers cellular endpoints with connectivity managed as a service. For small and mid-sized utilities (the majority of the ~50,000 US water systems), this lowers the capital and operational barrier to AMI adoption and shifts BMI’s revenue toward recurring connectivity and software. This is a genuine product-level differentiation, and management reports that seven of its nine large awarded projects are competitive conversions — i.e., share gains won on the cellular-plus-software value proposition.

Cyclicality and capital cycle. Municipal demand is comparatively stable — water is essential, budgets are rate-funded, and ~85% of meter demand is non-discretionary replacement — but it is not immune to budget timing, election cycles, and the lumpiness of large project awards. Through a Marathon/Capital-Returns lens, the AMI industry is mid-to-late in a favorable capital cycle: supply-side discipline is intact (no IPO flood, no capacity glut, rational pricing among an entrenched oligopoly), which supports the sustained ~20%+ ROIC. The nuance for BMI specifically is that it is currently in a post-boom project roll-off within an otherwise healthy long-cycle — a company-specific air pocket inside a structurally sound industry.

The AMI conversion economics — why the runway is long and the demand non-discretionary. The underlying unit demand is structurally defensive in a way that is easy to lose sight of amid the project-timing noise. A water meter is a legally-required, accuracy-degrading device with a finite life: as a mechanical meter ages it under-registers, costing the utility revenue, so replacement is not discretionary — it is a revenue-protection imperative driven by physics and regulation, not by capital-budget enthusiasm. Roughly 85% of BMI’s annual demand is this replacement-and-upgrade flow. Layered on top is the one-time conversion uplift as a utility moves from manual/AMR to AMI: a fixed-network or cellular AMI deployment replaces every endpoint in the system over a multi-year window, pulling forward years of replacement into a concentrated project — which is exactly why the project layer is lumpy even though the underlying demand is steady. With only ~40% of US meters AMI-converted and ~50,000 US water systems, the conversion runway extends well into the 2030s. Federal support (the IIJA’s water provisions and FEMA disaster funding for systems like Puerto Rico’s PRASA) accelerates the timing but is not the demand’s foundation; the foundation is aging infrastructure and non-revenue water loss, which exist regardless of the federal budget.

Marathon capital-cycle read. Through the Capital Returns lens, the absence of a supply-side capital flood is the tell of a healthy cycle: there is no IPO wave of new metering entrants, no capacity glut, and pricing among the entrenched oligopoly is rational (BMI passes tariff and commodity costs through list-price increases that stick). High returns (BMI’s ~21% ROIC) would, in a broken cycle, attract a flood of capital that competes them away; here the certification and reliability barriers prevent that entry, so the returns persist. The one cyclical wrinkle is intra-company, not intra-industry: BMI is in a post-boom project roll-off, the kind of demand “air pocket” the capital cycle predicts after a pull-forward — uncomfortable, but the opposite of a structural-oversupply problem.

Verdict: a structurally GOOD industry. Concentrated, high-barrier, secularly growing, supply-disciplined, and replacement-driven. Sustained ~21% ROIC across the cohort leader is the financial signature of an attractive structure. The risk is not the industry; it is the timing of BMI’s own project cadence within it.

4. Competitive Position

The moat — name the mechanism. Badger Meter’s competitive advantage is a layered customer-captivity moat, the strongest of Greenwald’s three genuine advantage types when paired with modest scale economies:

1. Switching and search costs at the utility. Once a water utility standardizes on ORION endpoints and the BEACON platform, it has trained its staff, integrated its billing and operations systems, and committed to a 15–20-year meter fleet. Ripping that out to switch vendors is costly, risky, and rarely worth it — particularly for a risk-averse public entity. This captivity is the core of the moat.
2. Razor/razorblade pull-through. Each installed meter and cellular endpoint pulls through recurring BEACON SaaS and ORION Cellular network-as-a-service revenue. The installed base becomes an annuity that compounds as AMI penetration rises — the recurring layer grew +53% in FY25 to ~10% of sales.
3. Brand and reliability. With municipal buyers who fear failure far more than they covet savings, a 120-year reputation for accuracy and reliability is a genuine asset and a barrier to challengers without a comparable track record.
4. Network-as-a-service lock-in. ORION Cellular shifts the relationship from a one-time hardware sale to an ongoing managed service, deepening the relationship and the switching cost.
5. Modest scale economies in radio/software R&D and the rep-distribution network, spread over a growing revenue base.

Financial proof of the moat. The framework demands that a moat surface in financial outcomes that would deteriorate without it. BMI’s do: ROIC rose from ~14.5% (FY18) to ~21.0% (FY25); gross margin from 37.4% to 41.7%; operating margin from 13.1% to 20.0%. Returns and margins expanding through a doubling of revenue is precisely what a durable advantage looks like — pricing power and mix benefit accruing to the incumbent rather than being competed away.

Direct comparison vs. peers. Against Itron — the AMI water share leader — BMI earns roughly 3x the ROIC (~21% vs. ~7%) on a more focused, higher-margin, debt-free model. Itron is larger and carries the broader fixed-network/grid franchise, but it is a structurally lower-return business. Against Mueller Water (valves/hydrants, mid-teens returns) and the Sensus/Neptune units buried inside Xylem and Roper, BMI is the highest-return pure-ish play on water metering. It screens, financially, with the AMETEK/Roper compounders rather than with the metering hardware peers.

Pressure-test — where the moat is thinner. Two honest caveats. First, the recurring annuity is still small (~10% of revenue), so the “SaaS switching-cost lock-in” is more a future than a present reality; the moat today rests on hardware captivity and brand, not a large contracted ARR base (and BEACON’s net-revenue-retention is undisclosed). Second, the hardware itself is partially commoditizing at the meter level — the differentiation is migrating to the radio, the connectivity, and the software, where Itron and Sensus are also investing. BMI is winning conversions today (7 of 9 awarded projects), but the cellular wedge is replicable, and a determined incumbent response on price or technology is a live risk.

Greenwald market-share-stability test. Greenwald’s most demanding moat test is whether market shares are stable — a sign that incumbents are protected and entrants cannot make inroads. The water-metering oligopoly passes: shares shift slowly, gated by the 15–20-year replacement clock (a utility’s vendor choice is locked for the life of the fleet) and by the reliability/certification barrier. BMI is actually gaining share at the margin (7 of 9 awarded projects are competitive conversions), which on the surface contradicts stability — but the gains are coming specifically on the cellular-AMI wedge, where BMI brought a genuinely differentiated product (managed connectivity, no utility-owned towers) to a market segment (small/mid utilities) that the fixed-network incumbents under-served. This is share gain earned through product innovation in an underserved niche, not price-driven share-buying — the healthy kind. The risk, again, is that the wedge is replicable; Itron and Sensus can and will offer cellular options, at which point the question becomes whether BMI’s installed-base captivity and software integration hold the gains.

Verdict: a durable competitive advantage — NOT a commoditizing hardware vendor. The ~21% ROIC, the rising margins through scale, and the conversion win-rate are real evidence of captivity and differentiation. But the “software annuity” story is ahead of the numbers, and the moat must be re-earned each cycle through the radio/software roadmap rather than resting on an entrenched subscription base. Strong, but to be monitored, not assumed permanent.

5. Growth History and Forward Opportunities

This section is the crux of the stock’s story — the gap between what grew and why.

The historical record (reported revenue growth):

Decomposing the boom. The 2021–24 surge was substantially transitory, a confluence of four factors that the market mistook for a durable run-rate:

1. Chip-shortage backlog catch-up. Like most electronics-bearing industrials, BMI built and then worked down an elevated order backlog through 2021–23, inflating reported growth as supply normalized.
2. A concentrated large-AMI project cohort (~800k connections) — JEA and OUC (supply-only), PCU and Galveston (turnkey) — that peaked in 2024 and declined through 2025. Turnkey projects in particular booked large revenue.
3. A pulled-forward cellular-AMI replacement wave as utilities adopted ORION Cellular faster than the steady-state replacement rate.
4. Acquisition. SmartCover ($185M, Jan-2025) contributed ~$39.7M (~5.5pp of FY25 growth); stripping it, organic utility-water growth in FY25 was ~7%, and total base growth was ~6.1% — already back to the secular rate before Q1’26 turned negative.

The air pocket — Q1 2026. Sales fell 9% YoY to $202.3M (utility water −9.6%); operating margin collapsed to 17.4% from a record 22.2% (a ~71% decremental margin — a stark reminder that earnings are far more volume-cyclical than the smooth 2023–24 ascent implied); EPS was $0.93 vs. $1.30. Two causes: the pre-signaled project trough (the new awarded cohort, including PRASA, does not ramp until 2H26) plus short-cycle orders running ~$15–20M below internal plan. Management — which does not normally guide — explicitly reset FY2026 organic revenue to “in line with 2025” (roughly flat) and cut executive salaries 10% for six months.

Why the project layer is both the engine and the noise. It is worth dwelling on the mechanics, because they explain the entire stock chart. A large AMI conversion is a multi-year, fixed-scope deployment: a utility awards (say) an 800k-connection project, and BMI ships meters, radios, and software against a deployment schedule that ramps, peaks, and then ends. When several such projects’ peaks coincide — as they did in 2023–24 — reported growth is supercharged; when that cohort finishes and the next cohort has not yet ramped — as in 2025–26 — revenue air-pockets even though the underlying replacement demand and the awarded backlog are intact. The 2023–24 cohort (~800k connections) is finishing; the next cohort (2.6–3.6M connections awarded) ramps from 2H26. The trough between cohorts is not a demand problem; it is a scheduling gap. The bear’s rejoinder — and it is a fair one — is that the short-cycle base orders also softened ~$15–20M below plan in Q1’26, which is not explained by project scheduling and could indicate genuine demand cooling at the distribution/utility level. Distinguishing the scheduling gap (benign) from base-demand softening (worrying) is the central diagnostic task, and it is unresolved until the 2H26 order book prints.

Forward opportunities — the bull’s runway:

• The awarded funnel is >3x larger. Awarded-but-not-started AMI projects total 2.6–3.6M connections over multiple years vs. the prior 800k cohort. Seven of nine are competitive conversions (share gains).
• PRASA (Puerto Rico). ~1.6M connections (~“8 Orlandos”), FEMA-funded, supply-only (higher margin), first purchase order received Q1’26, deployment ramping ~midyear 2026 — the single largest swing factor for the 2H26+ recovery.
• Recurring/software ramp. ~28% historical CAGR, +53% in FY25, with BEACON attaching ~100% to cellular radios; mix shift toward subscription should lift both growth quality and margin over time.
• Beyond-the-meter expansion. SmartCover + the UDLive UK sewer-monitoring acquisition (~$100M, closing Apr-2026, ~$22M TTM revenue) position BMI as a “global leader in sewer line monitoring” — a new recurring-revenue platform adjacent to the core.
• Water quality and international. s::can (quality), Syrinix (pressure), and geographic expansion beyond North America.

Verdict: a high-quality business with lower-quality, decelerating, lumpy near-term growth that is cresting now. The secular AMI conversion runway genuinely supports mid-to-high-single-digit organic growth over a cycle, augmented by the recurring ramp. But the 16–24% reported growth of 2023–24 was not the run-rate, and the market’s repricing — from a ~50x multiple that extrapolated the boom to a ~30x multiple that prices normalized growth — is the de-rating of a growth rate, not (yet) of business quality. Whether the trough is FY26 or whether normalized growth proves to be low-single-digit is the entire investment debate.

6. Financial Quality

Multi-year financial summary ($M unless noted):

The margin bridge. Revenue roughly doubled FY20→FY25 while gross margin expanded ~220bps to 41.7% and operating margin ~470bps to 20.0%, as SG&A fell from 24.2% to 21.7% of sales. The driver is mix, not accruals: ultrasonic meters, ORION Cellular, BEACON SaaS, and water quality all carry above-line-average margins, and management formally raised its normalized gross-margin band from 38–40% to 39–42% in Q3 2025, citing durable structural mix. Two cautions: FY25’s 41.7% sits at the top of that band (limited further upside), and FY26 faces copper/bismuth cost inflation in the brass-ingot recipe plus the operating deleverage already visible in Q1’26.

Quality of earnings — clean and high. This is a textbook clean-QoE name. Operating cash flow exceeds net income in every year (1.2–1.3x); the business is capex-light (~1.5% of sales); there are no one-time gains flattering FY25 net income; stock-based compensation is tiny ($9.2M, ~1.0% of sales); the pension overhang is negligible ($2.5M); and there is no off-balance-sheet leverage. Working capital is a tailwind as the chip-shortage inventory build unwinds — inventory days fell from 117 to 101 and the cash conversion cycle from ~122 to ~97 days over five years. GAAP net income tracks economic earnings; no normalization gymnastics are required (the opposite of the crypto/LNG/converts cases where GAAP is noise).

The one genuine quality caveat — earnings are more volume-cyclical than they looked. Q1 2026’s ~71% decremental operating margin is the tell: when project revenue rolls off, the SG&A and fixed-cost base deleverages hard. To make the math concrete — Q1’26 revenue fell ~$20M YoY while operating income fell ~$14M, so roughly 70 cents of every lost revenue dollar fell straight through to operating profit. That is the same operating leverage that powered the 2023–24 ascent, simply working in reverse, and it means a flat-revenue FY26 likely produces down earnings as the high-margin project mix recedes and copper/bismuth costs bite. The smooth 2023–24 margin chart disguised this; the recurring-software layer (~10%) is still too small to smooth it. Investors who underwrote a steadily-compounding margin story are confronting the reality that BMI’s near-term earnings have a meaningful cyclical/lumpy component — which is precisely why a “cheap” trailing P/E on those earnings deserves skepticism.

Working capital and cash conversion — a quiet tailwind. The chip-shortage era forced BMI to carry abnormally high inventory (component hoarding to protect production); as that normalizes, inventory days have fallen from 117 to 101 and the cash conversion cycle from ~122 to ~97 days, releasing working capital and lifting free-cash conversion above net income. This is a multi-year tailwind that is largely invisible in the income statement but real in the cash flow, and it helps explain why FY25 FCF (~$170M) comfortably exceeded net income ($141.6M). It also means reported FCF is, if anything, modestly flattered by the one-time inventory unwind — a factor to normalize when extrapolating forward FCF.

Balance sheet — a fortress. BMI carries zero long-term debt, even after the $185M SmartCover acquisition; its only facility is an undrawn $100M commercial-paper-backed revolver; it holds $226M net cash; and it can fund the $100M UDLive close and continued buybacks without leverage. Goodwill rose to ~$235.6M (~33% of equity) following SmartCover — the one balance-sheet item to monitor for impairment if the sewer-monitoring platform underperforms, though there is no current indication of that.

Verdict: economics decisively improve with scale. Rising ROIC, expanding margins, clean cash conversion, and a debt-free balance sheet through a doubling of revenue. The only asterisks are that margins are near peak and that the FY26 air pocket exposes more earnings cyclicality than the prior run-rate implied.

7. Capital Allocation

Verdict up front: management has allocated capital intelligently and is unusually owner-aligned.

M&A — disciplined serial bolt-on, stepping up in size. BMI’s history is a string of small, on-strategy acquisitions that broadened the platform from a meter maker into a water-data company: the Aquacue/BEACON software backbone (the cloud platform that turned hardware into a system), s::can (water-quality sensing, opening the “beyond-the-meter” category), Analytical Technology (ATi, water-quality instruments), and Syrinix (pressure/transient/leak monitoring). Each was small, adjacent, and capability-additive rather than scale-for-scale’s-sake — the right kind of bolt-on for a focused compounder. In the past 18 months BMI has stepped up in size: SmartCover/Hadronex ($184.0M, Jan-2025, ~4.6x sales), delivering ~$39.7M of FY25 revenue at ~25% growth, and UDLive (~$100M, ~4.5x sales, closing Apr-2026), ~$22M TTM revenue, EPS-accretive in year one. These are full SaaS-like multiples — not cheap — but they are building a genuine new recurring-revenue platform (sewer-network monitoring) adjacent to the core, funded entirely with balance-sheet cash. The strategic logic is sound: extend from clean-water metering into waste-water monitoring, where the same municipal customers, the same recurring-monitoring model, and the same data-platform competencies apply. The integration track record is good and the deals are individually digestible; the risks are (a) paying up at the top of a cycle, (b) the resulting goodwill (~33% of equity), and © a gradual drift up the size/price curve that could, if unchecked, strain the discipline that has characterized the smaller deals. So far the discipline holds.

R&D and reinvestment. BMI reinvests steadily in the radio/software roadmap (ORION Cellular, BEACON) that underpins the moat — the right place to spend, given that differentiation is migrating from the meter to the connectivity and software.

Dividend — a 33-year compounder. Badger Meter has raised its dividend for 33 consecutive years (a “Dividend Aristocrat”-class record), most recently +18% to $0.40/quarter, at a conservative ~31% payout. This is comfortably covered through the air pocket and signals management’s confidence in the through-cycle earnings power.

Buybacks — counter-cyclical and rational. Repurchases stepped up from $15M in FY25 to $38M in Q1’26 (256k shares) — buying into the ~45% drawdown — with $115M left on the authorization. Management explicitly framed FY25 buybacks as opportunistic, executed “when the market price implied an attractive long-term return.” Share count is essentially flat (~29.6M), so there is no dilution masking the per-share figures. Buying back stock counter-cyclically into a quality-business drawdown is exactly the disciplined behavior the framework rewards.

Incentive alignment — best-in-class. The 2026 proxy (DEF 14A) reveals genuinely well-designed incentives: the annual bonus is tied to adjusted EBITDA + absolute free cash flow, and the long-term PSUs are 50% free-cash-flow conversion + 50% ROIC over three years. These are precisely the metrics a capital-discipline-focused investor would choose — they reward returns on capital and cash generation, not revenue scale or vanity growth. CEO Bockhorst’s total comp is ~$5.93M (pay ratio ~126x), reasonable for the size and performance. The one limitation is low insider ownership (~1% total; CEO ~0.4%) — the incentives are well-structured, but management does not have large personal capital at stake.

Verdict. Intelligent, conservative, owner-aligned capital allocation: a fortress balance sheet, a disciplined and counter-cyclical buyback, a 33-year dividend record, sensible (if fully-priced) bolt-on M&A building a new recurring platform, and incentive metrics keyed to ROIC and FCF conversion. This is a clear positive for the thesis.

8. Changes and Headwinds — Last Two Years

Strategic moves.

• SmartCover/Hadronex acquisition ($185M, Jan-2025) — entry into sewer-line, lift-station, and stormwater monitoring; a new recurring-revenue platform.
• UDLive acquisition (~$100M, closing Apr-2026) — UK sewer-monitoring SaaS, paired with SmartCover to target global leadership in sewer-network monitoring.
• ORION Cellular and BlueEdge — continued push of the cellular network-as-a-service model and the integrated hardware-plus-software suite.
• Investor Day (May 21, 2026, NYC) — a long-term framing reset following the Q1’26 miss; the medium-term targets and capital-allocation framing communicated there are a key reference point to validate against subsequent results.

Capital returns. +18% dividend increase (33rd consecutive year); buyback authorization expanded and stepped up counter-cyclically.

The defining headwind — the growth air pocket. The dominant change is the deceleration itself, telegraphed across 2025 and confirmed in Q1’26: the large-AMI project cohort rolled off, short-cycle orders softened ~$15–20M below plan, FY26 organic guidance reset to roughly flat, operating margin deleveraged, and management cut executive salaries 10% for six months. The market’s response — a ~45% twelve-month decline and a P/E compression to the 6th percentile of the decade — is the principal “change” relevant to an investment decision today.

Cost and tariff headwinds. BMI reached price/cost parity on 2025 tariffs by Q4’25, using list-price increases (deliberately, rather than temporary surcharges, so the price holds if tariffs reverse). FY26 carries elevated copper and bismuth costs in the brass-ingot recipe — a gross-margin headwind on top of volume deleverage.

Leadership. No disruptive management or board change; CEO Bockhorst and CFO Wrocklage are in place and both bought stock personally into the drop. The 8-K record over the period is clean — no restatements, no litigation of note, no financing distress.

Verdict: net thesis-neutral-to-slightly-negative in the near term, but not thesis-breaking. The deceleration is real and was the right thing for the market to reprice; but the strategic moves (recurring-platform M&A, counter-cyclical buyback, dividend growth, insider buying) are constructive, and nothing in the two-year record impugns the business quality or capital discipline. The change that matters is cyclical/timing, not structural — if the bull’s framing is correct.

9. Risk Analysis

Risk synthesis. The dominant risk is interpretive: whether the deceleration is a timing trough (cyclical) or a regime change (structural). Most other risks (commodity, competitive, execution) are manageable and partially hedged by the balance sheet and the replacement-driven demand base. The probability of catastrophic loss is low — this is a debt-free, cash-generative, essential-infrastructure supplier — so the risk is principally to the multiple and the growth rate, not to solvency.

10. Valuation Discussion (Embedded Expectations)

No price target, no recommendation — this section frames embedded expectations and scenarios only.

The central valuation fact: BMI is cheap versus itself, not cheap on an absolute basis. This nuance is the whole valuation story and must not be flattened into “the stock got cheap.”

Own-history multiple trend (year-end multiples; current at $131.73):

The own-history valuation percentiles crystallize it: P/E 6th percentile (cheapest in a decade), composite 32nd, P/B 46th, P/S 45th.

The honest read — the P/E/P/S split matters. The earnings multiple has de-rated far harder than sales or book. Two reasons: (1) trailing EPS still carries the boom cohort, so the “cheap” P/E sits partly on peak earnings — normalize EPS toward a mid-cycle ~$4.50–4.75 and the multiple is higher and less flattering; (2) the market is repricing the embedded growth rate, which hits the earnings multiple most. On price-to-sales (45th percentile) and EV/Sales (~5.3x, roughly its 10-year average), BMI is mid-range of its own history — not washed out. The fair characterization is de-rated from nosebleed to merely full, not bargain.

Cross-sectional comps (rough, context only):

Even after −45%, BMI trades at a premium to the metering/water peer set — defensible on quality (3x Itron’s ROIC, rising gross margin, debt-free), and it genuinely screens with the AME/Roper compounders rather than the metering hardware names. But the cross-sectional read confirms the own-history read: cheap only versus itself.

Reverse-DCF / embedded expectations. At ~$4.90B EV, ~$184M FY25 free cash flow to the firm, ~zero net debt, and a 9% WACC:

• A no-growth perpetuity is worth ~$2.04B EV — far below the $4.90B market value, so the market is still paying meaningfully for growth.
• Solving for the implied steady-state growth: $4.90B = $184M / (0.09 − g) → g ≈ 5.25% perpetual FCF growth.

The de-rate has moved embedded expectations from the old ~50x P/E (which priced low-double-digit perpetual growth — “priced for perfection”) down to ~5.25% perpetual FCF growth — roughly the secular AMI conversion-plus-replacement rate plus the recurring-software ramp, lightly haircut for the FY26 air pocket. The price no longer prices the boom; it prices mid-single-digit. The investment debate is therefore narrow and precise: which side of mid-single-digit does normalized growth land?

Scenarios:

The peak-earnings adjustment — the most important valuation nuance. The headline “6th-percentile P/E” is the single most-cited bull datapoint, and it is the one that most deserves an asterisk. Trailing twelve-month EPS of ~$4.42 still embeds the tail of the boom cohort’s high-margin project revenue; on a normalized earnings base — flat-to-down FY26 EPS as the project mix recedes and deleverage bites, call it ~$4.40–4.75 mid-cycle — the forward P/E is closer to ~28–30x, not the optically cheap trailing figure. The reason P/S sits at the 45th percentile while P/E sits at the 6th is precisely this: sales have not collapsed (the denominator is steady), but the earnings multiple has de-rated both because the growth rate reset and because the market is implicitly haircutting the peak-margin E. An investor who anchors on the trailing P/E alone will overstate the cheapness; the honest anchor is EV/Sales (~5.3x, ~10-year average) and forward P/E (~28–30x), both of which say “fairly valued for the quality,” not “bargain.”

The dividend-yield floor. One modest valuation support: at ~$132 the ~$1.60 annualized dividend yields ~1.2%, near the high end of BMI’s own historical yield range (the stock historically yielded well under 1% at its premium multiples). For a 33-year dividend grower with a ~31% payout and a debt-free balance sheet, the rising yield provides a soft valuation floor and a total-return cushion that did not exist at the ~50x peak — a small but real change in the risk/reward.

What must be true for today’s price. The current ~$131 broadly discounts the base case — that FY26 is the trough, normalized organic growth resumes at mid-to-high-single-digit as the awarded funnel ramps, gross margin holds in the 39–42% band, and the multiple stabilizes near 28–34x. Pay less than that and you are buying the bear’s downside protection; pay more and you are pre-paying for the bull’s re-acceleration.

11. Variant Perception

Consensus belief. The sell-side is constructively positioned — roughly 7 Buy / 5 Hold / 1 Sell, with average price targets clustering ~$190–220 versus the ~$132 spot (one conservative aggregate near $147). EPS is expected to grow ~32% over three years. The Street reads the decline as a timing air pocket / buy-the-dip — not a structural break. This is important: the variant-perception edge is not “the Street is wildly bullish and wrong”; the Street already sees a timing trough. The edge, if any, is in correctly calling trough-vs-regime-change with more conviction than the divided Hold-heavy ratings imply.

The strongest bull case. A wide-moat, debt-free water compounder (~21% ROIC, gross-margin band raised to 39–42%, 33-year dividend grower) has been oversold ~45% on a deceleration that management telegraphed and that is rooted in project timing, not demand destruction — “nothing gets cancelled, it only moves right.” The awarded funnel is >3x the prior cohort, seven of nine awards are competitive conversions (share gains), the recurring layer compounds at ~28%, insiders bought aggressively into the drop, and the multiple has reset to the 6th percentile of its decade. If FY26 is the trough, an investor is buying a high-quality compounder at a reasonable price for the first time in years.

The strongest bear case. The 2021–24 boom was a one-time confluence — chip-shortage backlog catch-up, a pulled-forward cellular-AMI wave, lumpy turnkey projects, and one acquisition — and normalized organic growth is mid-single-digit and lumpy, which does not deserve a ~30x/22x multiple that sits at a premium to ROIC-lighter peers. The “cheap” P/E is an artifact of peak earnings; on price-to-sales the stock is only mid-range. The Q1’26 short-cycle shortfall ($15–20M below plan) may signal softening demand, not just project timing. The multiple can compress toward the peer 18–22x even if estimates hold — a painful de-rate from here without any earnings miss.

The 3–5 assumptions that matter most, and what falsifies each:

1. FY26 is the trough. Falsified if Q2/Q3 2026 short-cycle orders stay soft or awarded projects slip further right.
2. Normalized organic growth is ≥ mid-single-digit. Falsified if 2027 organic settles at low-single-digit.
3. The awarded funnel (PRASA + 8 others) converts to revenue 2027–30. Falsified if purchase orders stall (Puerto Rico/FEMA/hurricane execution risk).
4. Gross margin holds in the 39–42% band. Falsified if margin breaks below 39% on copper/bismuth plus deleverage.
5. The multiple stabilizes near 28–34x. Falsified if it compresses to peer 18–22x.

The factor read — this is an idiosyncratic bet. A factor/risk model shows the −45% is overwhelmingly company-specific: loadings are dominated by Market with an R² of just 0.21 (~79% idiosyncratic), so this is not a factor rotation or a value-trap-style style unwind. The y1 return is −45.6% (Sharpe −1.08, max drawdown −54%), but the price ($131.73) sits below the 200-EMA (~$156) and above the 50-EMA (~$130) — a falling knife that has very recently stopped falling and is attempting to base. Low beta (0.93) and a DividendYield loading frame it as a quality/dividend name de-rated on company-specific news. The implication: this is a company-specific cycle-timing bet, not a macro or factor bet. Consensus already leans “timing”; the variant edge is in the conviction and the entry, not in a contrarian read of the diagnosis.

Where the genuine variant perception sits. Because the Street and management agree on the “timing” framing, the real differentiated views are at the two tails. The first non-consensus view is more bearish than the Hold-heavy Street: that the market is anchoring on the 6th-percentile trailing P/E as evidence of cheapness while ignoring that the multiple is on peak-margin earnings and still a premium to peers — i.e., the stock could be a value trap that de-rates further toward the peer 18–22x even if the timing thesis is right, simply because quality compounders that lose their growth premium often over-correct. The second non-consensus view is more bullish than the Street’s tepid average target: that a debt-free, ~21%-ROIC, share-gaining compounder with a >3x funnel and insider buying, trading at the cheapest multiple of its decade, is being handed to long-term owners at a price that will look obviously attractive in three years regardless of the exact trough quarter — and that the precise timing of the 2H26 recovery is noise to a multi-year holder. Both views are internally coherent; which one is right depends almost entirely on whether normalized organic growth proves to be mid-single (bullish) or low-single (bearish), and on whether the market re-rates quality or punishes the lost growth premium. That is the crux the next several quarters will adjudicate.

12. Fact vs. Interpretation

13. Open Questions

1. Is the Q1’26 short-cycle shortfall ($15–20M below plan) timing or demand? Management calls it timing; it is the single most important unresolved question. The 2H26 order trajectory will answer it.
2. What is BEACON’s actual ARR and net revenue retention? The recurring layer is strategically central but its underlying SaaS metrics are undisclosed — we cannot independently verify the “100% recurring, 28% CAGR” durability or the churn profile.
3. Will PRASA (and the broader 2.6–3.6M-connection funnel) convert on schedule? First PO received Q1’26; Puerto Rico/FEMA/hurricane execution risk is real and the timing drives the entire 2H26+ recovery.
4. Where does normalized organic growth settle — mid-single or low-single-digit? The difference is the whole valuation debate.
5. Can gross margin hold the 39–42% band against copper/bismuth/tariff inflation and volume deleverage?
6. What did the May 21, 2026 Investor Day commit to for medium-term growth and margin targets, and how do subsequent results track against it?
7. Will management remain disciplined on M&A multiples if it continues building the sewer-monitoring platform, or does the appetite for full-priced bolt-ons grow into the cycle?

14. What Must Be True

For the bull case to be right (the timing-trough thesis):

• FY2026 is the earnings trough, with Q2/Q3 short-cycle orders re-accelerating and the awarded project funnel beginning to ramp in 2H26.
• Normalized organic growth resumes at mid-to-high-single-digit as PRASA and the >3x funnel convert through 2027–30.
• Gross margin holds in the 39–42% band; the recurring layer continues compounding and gradually lifts mix.
• The multiple stabilizes near 28–34x and re-rates as growth re-accelerates.
• Falsification test: if FY2026 organic growth comes in below flat, or Q2/Q3 2026 short-cycle orders fail to recover and the awarded projects slip further right, the timing thesis is broken — the deceleration is structural, and the premium multiple is unjustified.

For the bear case to be right (the regime-change thesis):

• The 2021–24 boom was a one-time pull-forward; normalized organic growth settles at low-single-digit and lumpy.
• Earnings prove materially more cyclical than the 2023–24 run-rate implied (Q1’26’s ~71% decremental margin as evidence).
• The multiple compresses toward the peer 18–22x as the market reprices BMI from “compounder” to “cyclical metering hardware vendor with a software option.”
• Falsification test: if normalized organic growth re-establishes a durable mid-single-digit-or-better trajectory through 2027 and the recurring layer scales past ~15% of revenue with disclosed retention, the regime-change thesis is broken — BMI is a quality compounder that was simply over-extrapolated and is now fairly priced.

The pivot. Both falsification tests run through the same clock: the 2H26 short-cycle order recovery and the on-time ramp of the awarded funnel (led by PRASA). An investor does not need to resolve the debate in the abstract; the next two to three quarters of orders and project ramps will largely settle it.

A source appendix follows (Appendix B). All financial figures reconciled to BMI’s FY2025 10-K, Q1-2026 10-Q, and DEF 14A 2026, with third-party aggregated financial data and a factor/risk model as secondary/cross-check sources; management commentary from the Q2’25–Q1’26 earnings calls is treated as hypothesis validated against filings.

APPENDIX A — Standard Diligence Questionnaire

Badger Meter, Inc. (NYSE: BMI) — as of June 14, 2026

Supplemental to the analysis above. Fact/Interpretation/Assumption labels applied where material.

General

What thoughtful questions have other investors asked about this company? The dominant questions cluster on growth durability: (1) Was the 2021–24 growth (16–24%) a sustainable run-rate or a transitory backlog/project boom? (Answer: substantially transitory — Interpretation, supported by base-growth deceleration to 6.1% in FY25 and a guide to flat FY26.) (2) Is the recurring/software layer (~10% of sales) large enough to justify a “SaaS” valuation premium? (Interpretation: not yet — it is real and fast-growing but immaterial to current economics.) (3) Does BMI deserve a premium to Itron/Mueller given 3x their ROIC, or is it just a higher-quality cyclical? (4) Is the Q1’26 short-cycle shortfall timing or demand? Investors have also probed margin durability (the 39–42% band vs. copper/bismuth costs) and PRASA execution risk.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Below the 2024–25 peak and likely near a cyclical/timing trough — FY26 is guided to roughly flat with Q1’26 down 9% and a ~71% decremental operating margin. The 2023–24 record margins (op margin 20%, peaking at 22.2% in a quarter) reflected a project/volume peak. (Interpretation.)

Driven by external environment or internal actions? Both. Internal: ORION Cellular adoption, mix shift to ultrasonic/software, and won project conversions. External: the AMI replacement cycle, IIJA/FEMA funding, municipal budget timing, and chip-shortage backlog dynamics. The current air pocket is primarily project-timing (internal cadence) layered on softer short-cycle orders.

How stable are revenues? The base (~85% non-discretionary meter/radio replacement) is stable; the large-project layer is lumpy and creates significant quarter-to-quarter volatility (and effective customer concentration via project pacing).

Outlook for products/services? Secularly favorable — multi-decade AMI conversion runway (only ~40% of US meters converted), expanding recurring software, and a new sewer-monitoring platform (SmartCover/UDLive).

How big is this market — growing, shrinking, domestic or international? Global smart-water-metering ~$9B (2024) → ~$16B (2030), ~10% CAGR; predominantly North American for BMI today, with international expansion underway. Growing.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Stable — a concentrated, high-barrier oligopoly (Itron, Sensus/Xylem, Neptune/Roper, Mueller, Kamstrup, Diehl). The technology axis (cellular vs. fixed-network) is the active competitive frontier.

How profitable is the business (ROIC, ROE)? Very — ROIC ~21%, ROE ~22% (FY25), both having risen materially over five years. (Fact.)

How profitable is the industry? Attractive for the leaders; BMI earns ~3x Itron’s ROIC. High barriers (certifications, 15–20-year reliability requirements, entrenched distribution) support durable returns.

Can the business be easily understood? Yes — water meters + radios + software sold to utilities. The complexity is in project cadence and supply-vs-turnkey mix.

Can it be undermined by foreign low-cost labor? Low risk — the moat is reliability, certification, software, and the installed base, not labor cost; municipal buyers are risk-averse and US-content/Buy-American-oriented.

Do brands matter? Yes — 120-year reliability reputation matters greatly to risk-averse public-utility buyers.

Nature of competition? Technology (cellular/software), reliability track record, and total-cost-of-ownership — not primarily price.

Customers’ switching costs? High once standardized on ORION/BEACON — staff training, billing/ops integration, and a 15–20-year meter fleet. The core of the moat.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The installed base / recurring-revenue annuity and the brand are not capitalized — economic assets understated. (Interpretation.)

Off-balance-sheet liabilities? None material — negligible pension ($2.5M), no off-balance-sheet leverage, an undrawn $100M revolver.

How conservative is the accounting? Conservative and clean — OCF exceeds NI every year (1.2–1.3x), tiny SBC (~1% of sales), no one-time gains flattering earnings. High quality of earnings.

How CapEx-hungry is the business? Light — capex ~1.5% of sales. Free-cash-flow conversion is high.

Capital Allocation & Management

How much FCF, and how is it used? ~$170M FY25 FCF. Used for: bolt-on M&A (SmartCover $185M, UDLive $100M), a 33-year-growing dividend (~31% payout), and counter-cyclical buybacks ($38M Q1’26). Funded entirely from cash; no leverage.

Significant acquisitions recently? SmartCover/Hadronex ($185M, Jan-2025, ~4.6x sales) and UDLive (~$100M, closing Apr-2026, ~4.5x sales) — building a sewer-monitoring recurring platform. Full multiples but on-strategy.

Buying back shares? Yes, counter-cyclically into the drawdown ($38M Q1’26; $115M authorization remaining); share count flat (~29.6M), no dilution.

Issuing large amounts of stock to insiders? No — SBC is ~1% of sales; share count is essentially flat.

Compensation policy of directors/management? Well-designed: bonus on adjusted EBITDA + absolute FCF; LTI PSUs on 50% FCF-conversion + 50% ROIC over three years — best-in-class capital-discipline metrics. CEO comp ~$5.93M. (Fact.)

Motivations of management? Incentives well-aligned to returns and cash; the one caveat is low insider ownership (~1%; CEO ~0.4%). Notably, the CEO and CFO each made open-market purchases into the 2026 drawdown — a conviction signal. (Fact + Interpretation.)

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — ordinary NYSE-listed US C-corp common stock; issues a 1099.

Dividend policy? 33 consecutive years of increases, most recently +18% to $0.40/quarter, ~31% payout, ~1.2% yield. Conservative and growing.

How profitable is the business? ~15% net margin, ~21% ROIC, ~22% ROE.

Is net income diverging from cash from operations? No — OCF exceeds NI every year (1.2–1.3x). Clean.

Risks & Downside

What factors would cause the stock to decline (further)? A confirmation that the deceleration is structural (FY26 below flat, soft 2H26 orders); margin breaking below 39%; a further multiple compression toward peer 18–22x (the stock is still a premium to peers and trades on partly-peak earnings); PRASA/funnel slippage.

Risk of catastrophic loss? Low — debt-free, net cash, essential replacement-demand product. The risk is to the multiple and growth rate, not solvency.

Chance of total loss? Negligible — a profitable, cash-generative, debt-free 120-year-old infrastructure supplier.

Recent News & Events

Has the business environment changed recently? Yes — the defining recent change is the growth air pocket: the large-AMI project cohort rolled off, Q1’26 sales fell 9%, and FY26 organic guidance reset to ~flat. The stock fell ~45% over twelve months and de-rated to the 6th-percentile P/E of its decade.

Significant acquisitions? SmartCover (Jan-2025) and UDLive (closing Apr-2026).

Change in accounting policies? None material.

Recent changes — new markets, facilities, management? New sewer-monitoring platform (SmartCover/UDLive); ORION Cellular and BlueEdge push; Investor Day (May 21, 2026) reset medium-term framing; no disruptive management change (CEO Bockhorst and CFO Wrocklage in place, both bought stock personally).

APPENDIX B — Source Appendix

Badger Meter, Inc. (NYSE: BMI) — Research as of June 14, 2026

Primary sources prioritized over secondary; recent over stale. Management commentary treated as hypothesis and validated against filings.

Primary — SEC Filings (EDGAR, CIK 0000009092)

• Form 10-K, FY2025 (filed 2026-02-17) — bmi-20251231.htm. Segment/product-line revenue (Utility Water ~$816M / Flow Instrumentation ~$101M), recurring/over-time revenue ($89.7M, 9.8% of sales), gross/operating margins, balance sheet (debt-free, $226M net cash), SmartCover purchase accounting, goodwill.
• Form 10-Q, Q1 2026 (filed 2026-04-20) — bmi-20260331.htm. Q1’26 sales −9% to $202.3M, operating margin 17.4%, diluted EPS $0.93, buyback ($38M / 256k shares), UDLive pending.
• Form 10-K filings, FY2021–FY2024 — multi-year revenue, margin, cash-flow, and ROIC series.
• DEF 14A Proxy Statement (filed 2026-03-13) — bmi-20260311.htm. Executive compensation: annual bonus (adjusted EBITDA + absolute FCF); LTI PSUs (50% FCF-conversion + 50% ROIC, 3-year); CEO total comp ~$5.93M; pay ratio ~126x; insider ownership.
• Form 4 filings, 2026 (EDGAR, CIK 9092) — open-market purchases: Bockhorst (CEO) 3,300 sh @ $152.42 (2026-02-10) and 2,200 sh @ $117.53 (2026-04-21); Wrocklage (CFO) 1,650 @ $152.35 (2026-02-09) and 1,000 @ $122.35 (2026-04-23); Htwe, Tarantino, Callahan (officers) clustered 2026-04-21 at $113–116. ~11,578 shares / ~$1.53M total; all other activity routine grants/withholding/exercises.
• Form 8-K filings, 2024–2026 — earnings releases, SmartCover and UDLive acquisition announcements, buyback authorization, dividend increases. Clean record (no restatements/litigation/financing distress).

Primary — Earnings-Call Transcripts

• Q1 2026 call (2026-04-17) — Bockhorst & Wrocklage. The guide-down: FY26 organic ~flat; short-cycle orders $15–20M below plan; project trough; awarded funnel 2.6–3.6M connections; PRASA first PO; 10% exec salary cut.
• Q4 2025 call (2026-01-28) — base FY25 growth 6%; PRASA 1.6M-connection award; software ~$74M/8%, 28% CAGR.
• Q3 2025 call (2025-10-21) — normalized gross-margin band raised to 39–42%; “lower growth first-half 2026, higher second-half.”
• Q2 2025 call (2025-07-23) — telegraphed AMI projects wrapping in Q2; Q3 sequential sales decline; dividend +18%.

Secondary — Quantitative Data

• Aggregated financial data services — profitability ratios (ROIC, ROE, margins), enterprise value (EV ~$4.9B FY25), valuation multiples (own-history trend), income statement/balance sheet/cash flow (multi-year). Reconciled to filings.
• Own-history valuation percentiles (as of 2026-06-12) — : composite 32nd, P/E 6th, P/B 46th, P/S 45th; price $131.73, TTM EPS $4.42.
• Price history — OHLCV, EMAs (200-EMA ~$156, 50-EMA ~$130), beta 0.93, alpha −0.226.
• Factor / risk model — stock-info (rs_12m −45.74, beta), loadings (Market-dominated, R² ~0.21 = idiosyncratic), leaderboard (y1 −45.6%, Sharpe −1.08, maxDD −54%).

Secondary — Industry & Market

• Smart-water-metering market sizing (~$9B 2024 → ~$16B 2030, ~10% CAGR) — Grand View Research / MarketsandMarkets (industry aggregates).
• Peer financial context — Xylem (XYL), Itron (ITRI), Mueller Water (MWA), A.O. Smith (AOS), AMETEK (AME), Roper, Danaher (DHR) — public filings and market data.
• Sell-side consensus / price targets — public aggregators (WallStreetZen, Investing.com, MarketBeat): ~7 Buy / 5 Hold / 1 Sell; average PT ~$190–220 (conservative aggregate ~$147).

Notes on Method

• All material financial figures reconciled to BMI’s SEC filings; third-party data services were used for ratios, own-history valuation context, and factor positioning, then cross-checked against the 10-K/10-Q.
• No price target or buy/sell recommendation appears in the analysis body; the single position-taking block (Claude’s Take) is explicitly labeled as a subjective view.